LINKSTER
LIVE

Serial Number

79304264

Owner

Linkster Therapeutics AG

Attorney

Dianne M. Smith-Misemer

Filing Date

Dec 15, 2020

Add to watchlist:

No watchlists yet
View on USPTO

LINKSTER Trademark

Serial Number: 79304264 • Registration: 6617265

LINKSTER is a trademark filed by Linkster Therapeutics AG on December 15, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Linkster Therapeutics AG (3 trademarks)

Stampfenbachstrasse 142

Entity Type: 25

Trademark Details

Filing Date

December 15, 2020

Registration Date

January 18, 2022

Published for Opposition

November 2, 2021

Goods & Services

Pharmaceutical preparations, medical and veterinary preparations for veterinary preparations for treatment of intestinal bacteria, enzyme preparations for medical use, pharmaceutical preparations for wounds; hygienic products for medical use, namely, sanitary preparations for medical use; dietetic food, adapted for medical and veterinary use; diagnostic preparations for scientific use, namely, drugs in the nature of drug testing kits comprised of medical diagnostic reagents and assays that test for the presence of alcohol, drugs

Scientific Research Services for identification and quantification of molecules, in particular polypeptides, from a series of molecules; scientific research services using a series of bar codes for identifying the molecule selected by mass spectrometry; Laboratory analyses in the field of molecular biology; consultancy in the field of technological research in the technology field of computer hardware systems, informational technology; consultation advice relating to research and development in the field of therapeutic procedures; consulting services in the field of pharmaceutical research; consulting services for gene therapy research in the field of pharmaceutical research and genetic science; provision of information and data about medical and veterinary laboratory research and development; biochemical and biotechnological research and development; scientific and technological services, namely, research, testing and computer-aided scientific analysis in the field of treatment of intestinal bacteria, enzyme preparations for medical use, pharmaceutical preparations for wounds; Scientific research in the field of proteins, antibodies, microorganisms and cells; computer software development

Diagnostic preparations for scientific and research purposes; diagnostic reagents for scientific and research purposes; diagnostic preparations for scientific use, namely, molecules, antibodies, nanobodies, peptides and target molecules, namely, diamond molecules and derivatives for use in nanotechnology, microelectronics, optics, and pharmaceuticals; chemical and biochemical substances, chemical materials and chemical preparations as well as natural elements, namely, molecules, for scientific and research use, namely, chemical substances for analyses in laboratories, other than for medical or veterinary purposes, chemical preparations and substances used to denature other chemical substances by rendering them unsuitable for human and animal consumption, Diamond molecules and derivatives for use in nanotechnology, microelectronics, optics, and pharmaceuticals

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Dec 4, 2025 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Dec 18, 2022 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 18, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jun 29, 2022 FICS
FINAL DISPOSITION PROCESSED
Jun 29, 2022 FIMP
NEW REPRESENTATIVE AT IB RECEIVED
May 22, 2022 NREP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 18, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Jan 18, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 2, 2021 NPUB
PUBLISHED FOR OPPOSITION
Nov 2, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 13, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 24, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 23, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 23, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 23, 2021 TROA
REFUSAL PROCESSED BY IB
Jul 5, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 17, 2021 RFCS
REFUSAL PROCESSED BY MPU
Jun 17, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 16, 2021 RFCR
NON-FINAL ACTION WRITTEN
Jun 15, 2021 CNRT
ASSIGNED TO EXAMINER
Jun 8, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 23, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 19, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 18, 2021 REPR